Veterinary Catheters Market By Product Type (Peripheral Intravenous Catheters, Central Venous Catheters, Urinary Catheters, Specialty Catheters), By Animal Type (Companion Animals, Livestock Animals, Equine), By Application (Fluid Therapy and Drug Administration, Urinary Drainage and Management, Blood Collection and Transfusion, Surgery and Critical Care), By End User (Veterinary Hospitals and Clinics, Veterinary Diagnostic and Research Laboratories, Academic and Research Institutes), By Geography, Segment Revenue Estimation, Forecast, 2026–2032

Veterinary Catheters Market: Essential Medical Devices Driving Modern Animal Care, Critical Treatment Delivery, and Advanced Veterinary Clinical Outcomes

The Global Veterinary Catheters Market was valued at USD 0.83 billion in 2025 and is projected to reach USD 1.28 billion by 2032, expanding at a CAGR of 6.4% during 2026–2032.

 

Veterinary catheters are medical tubes used in animal care for fluid and medicine delivery, urine drainage, blood pressure monitoring, anesthesia support, and critical care. Their demand is increasing as veterinary hospitals expand surgical, emergency, intensive care, and long-duration treatment capabilities.

 

Peripheral IV catheters remain widely used because veterinarians need rapid vascular access for fluid therapy, medication administration, anesthesia, and emergency stabilization. Central venous catheters serve animals requiring prolonged infusions, nutritional support, drug delivery, or continuous monitoring, making them increasingly relevant in advanced veterinary hospitals and critical care units. Urinary catheters are essential for bladder drainage, urinary obstruction management, and kidney-output monitoring, particularly in companion animals. Specialty products such as red rubber and oxygen-delivery catheters support surgical and procedure-specific applications.

 

Polyurethane and silicone catheters are preferred for longer use because of their flexibility and reduced irritation, while more rigid materials may be selected for short-term procedures. Smaller sizes such as 3.5 Fr to 5 Fr are commonly suited to cats and small animals, whereas 8 Fr to 10 Fr or larger sizes are used for larger dogs depending on clinical requirements.

 

Manufacturers including Jorgensen Laboratories, MILA International, and Cardinal Health supply vascular, urinary, and specialty veterinary catheter products. Competition increasingly centers on product reliability, ease of placement, patient comfort, infection prevention, broader size availability, and dependable distribution. Quality systems such as ISO 13485 and applicable regional conformity requirements also remain important for suppliers serving international veterinary markets.

 

Why Is Veterinary Catheter Utilization Increasing Across Hospitals and Clinics?

Catheter demand rises primarily when more animals undergo procedures requiring anesthesia, fluid therapy, hospitalization, surgery, emergency stabilization and intensive monitoring. AAHA's 2024 Fluid Therapy Guidelines state that IV catheters should be placed in all patients undergoing anesthesia. The recommendation gives vascular-access products a large recurring role beyond critically ill animals because anesthesia is used across surgery, dentistry, diagnostic procedures and other interventions. AAHA also notes that IV access allows rapid administration of additional anesthetic agents, analgesics, fluids and emergency medications.

Veterinary capacity is expanding alongside this treatment intensity. The U.S. Bureau of Labor Statistics recorded approximately 86,400 veterinarian jobs in 2024 and projects employment to reach 94,700 by 2034, representing 10% growth. Approximately 84% of veterinarians worked in veterinary services in 2024, placing most professional capacity directly within settings that routinely consume catheters and associated supplies. BLS attributes growth partly to increasing pet-related expenditure, an expanding and aging pet population, and more advanced treatment options.

Veterinary technicians further increase procedural capacity. BLS expects employment of veterinary technologists and technicians to grow 9% from 2024 to 2034, with approximately 14,300 openings annually. Greater technician utilization is commercially important because catheter placement, maintenance, fluid administration and hospitalized-patient monitoring are labor-intensive activities. Practices that delegate these tasks appropriately can increase treatment throughput without requiring veterinarians to perform every procedural step.

 

Why Are Peripheral IV Catheters One of the Most Recurrent Product Categories?

Peripheral IV catheters sit at the intersection of anesthesia, emergency care and general hospitalization. AAHA describes IV fluid therapy as common across clinical conditions ranging from temporary inadequate intake to renal disease, major volume loss and shock. The guidelines also recommend IV access during anesthesia and discuss catheter maintenance even when an animal is not continuously receiving fluids.

This creates high replacement frequency because most peripheral devices are short-duration consumables rather than permanent implants. Purchasing therefore depends on more than unit price. Veterinarians consider ease of placement, catheter gauge, kink resistance, dwell performance, vein compatibility, securement and connection design because catheter failure can force another placement and consume staff time.

The treatment setting also determines the catheter specification. Emergency patients may require relatively large-bore access for rapid fluid administration, while cats, puppies and other small animals require substantially smaller devices. Large animals create another product tier entirely. B. Braun Vet Care, for example, offers the Braunüle Vet High Flow catheter specifically for horses and cattle, emphasizing high flow, fixation wings, an atraumatic tip and polyurethane construction. This product diversity prevents the category from becoming a completely standardized commodity.

 

Why Does Feline Urethral Obstruction Create a High-Value Urinary Catheter Demand Pool?

Male-cat urethral obstruction is one of the clearest procedure-linked drivers for veterinary urinary catheters. A VetCompass study covering 237,825 male cats treated in UK primary veterinary care identified 1,293 incident urethral-obstruction cases, corresponding to an estimated annual incidence risk of 0.54% in the 2016 study population. Although the incidence figure should not be extrapolated directly to every country, the study demonstrates a measurable population of cats requiring urgent intervention and catheter-based management.

More recent evidence shows how intensively catheters can be used once these animals reach referral hospitals. A 2026 multicentre study of 601 male cats undergoing urethral catheterization found that 53 animals, or 8.8%, required repeat catheterization. Azotaemic cats were 1.92 times more likely to undergo longer catheterization and 1.81 times more likely to remain hospitalized longer than non-azotaemic cats. Among 127 cats monitored until their azotaemia resolved, 70.1% normalized within 48 hours and 91.3% had resolved by 60 hours. Overall survival to discharge was 98.5%.

The 2025 iCatCare consensus guidelines add a strong product-design and infection-control dimension. They state that urinary catheters should not be left draining openly because of infection risk and describe usual indwelling durations of approximately 24–36 hours, except when conditions such as azotaemia require longer management. The guidelines cite acquired bacteriuria in approximately 13% of catheterized cats in one study and emphasize aseptic placement and closed collection systems.

These recommendations increase the commercial importance of atraumatic catheter tips, flexible materials, luer-lock connections, adjustable lengths, anti-kink performance, securement and closed urine-collection systems. Suppliers that combine the catheter with drainage, extension and securement products can therefore capture more revenue from each obstructed-cat episode than suppliers competing only with an individual catheter SKU.

 

What Are the Key Dimensions Defining the Veterinary Catheters Market Landscape?

Peripheral Intravenous Catheters accounted for 42.0% of the Veterinary Catheters Market in 2025, representing an estimated USD 348.6 million in revenue, and the segment is projected to grow at a 5.8% CAGR. Their leading position reflects recurring use across anesthesia, fluid therapy, surgery, emergency stabilization and hospitalized-animal care.

Central Venous Catheters represented 21.0% of the market in 2025, equivalent to approximately USD 174.3 million, and are projected to expand at a 6.9% CAGR. Growth is supported by greater use in critical care, extended hospitalization, repeated drug administration, parenteral nutrition and longer-duration vascular access.

Urinary Catheters held a 24.0% market share in 2025, generating an estimated USD 199.2 million, with the segment projected to grow at a 6.4% CAGR. Demand is closely linked to urinary drainage, monitoring and management of conditions such as feline urethral obstruction, where indwelling catheterization and closed collection systems are frequently required.

Specialty Catheters accounted for 13.0% of the market in 2025, representing approximately USD 107.9 million, and are projected to record the fastest growth at a 7.9% CAGR. Increasing adoption of PICCs, extended-dwell devices, large-animal catheters, balloon catheters and other procedure-specific products is supporting this higher growth rate.

 

Animal Segmentation Landscape: Companion, Livestock, and Equine Demand Drivers

Companion Animals represented the largest animal-type segment with a 64.0% share in 2025, equivalent to an estimated USD 531.2 million, and are projected to grow at a 6.7% CAGR. Large dog and cat populations, rising veterinary expenditure, anesthesia procedures, emergency treatment and specialty care continue to drive catheter consumption in this segment.

Livestock Animals accounted for 23.0% of the market in 2025, generating approximately USD 190.9 million, and are projected to expand at a 5.7% CAGR. Catheters are used in fluid administration, treatment delivery, blood collection and other veterinary procedures involving cattle and other production animals.

Equine applications represented 13.0% of the market in 2025, equivalent to about USD 107.9 million, with a projected 6.1% CAGR. Demand is supported by surgery, emergency fluid resuscitation, intensive care and the need for durable large-bore vascular-access products suitable for horses.

 

Application Spectrum Driving Veterinary Catheter Utilization Across Clinical Care Pathways

Fluid Therapy and Drug Administration accounted for the largest application share at 40.0% in 2025, representing an estimated USD 332.0 million, and are projected to grow at a 6.1% CAGR. Routine IV access during anesthesia, hospitalization, emergency stabilization and therapeutic fluid administration keeps this application at the center of veterinary catheter utilization.

Urinary Drainage and Management represented 23.0% of the market in 2025, equivalent to approximately USD 190.9 million, and are projected to expand at a 6.4% CAGR. Feline urethral obstruction, urinary retention, urine-output monitoring and closed drainage requirements support recurring catheter demand.

Blood Collection and Transfusion accounted for 15.0% of market revenue in 2025, or approximately USD 124.5 million, with a projected 5.8% CAGR. The segment is supported by hospitalized and critically ill animals requiring repeated blood sampling, transfusion access and vascular monitoring.

Surgery and Critical Care held a 22.0% share in 2025, generating an estimated USD 182.6 million, and are projected to grow at a 7.3% CAGR. The relatively high growth rate reflects increasing veterinary specialization, longer inpatient treatment, emergency procedures and demand for more reliable extended-dwell and central vascular access.

 

End-User Landscape: Where Veterinary Catheters Are Most Intensively Utilized Across Clinical and Research Settings

Veterinary Hospitals and Clinics dominated the end-user segment with a 70.0% market share in 2025, equivalent to approximately USD 581.0 million, and are projected to grow at a 6.6% CAGR. Their leading position reflects the concentration of surgery, anesthesia, fluid therapy, emergency treatment, urinary catheterization and inpatient monitoring within clinical settings.

Veterinary Diagnostic and Research Laboratories represented 17.0% of the market in 2025, generating an estimated USD 141.1 million, and are projected to expand at a 5.9% CAGR. Catheters support controlled blood collection, sample collection, research procedures and other laboratory-based veterinary activities.

Academic and Research Institutes accounted for 13.0% of the market in 2025, equivalent to approximately USD 107.9 million, with a projected 6.0% CAGR. Veterinary teaching hospitals, universities and research centers use routine and specialty catheter products for clinical education, advanced treatment, experimental procedures and animal-health research.

 

How Are Leading Veterinary Catheter Companies Redefining Clinical Access Through Specialized, System-Based Innovation?

Jorgensen Laboratories (JorVet): Broad, Multi-Segment Veterinary Catheter Portfolio with Expanding Clinical Applications

Jorgensen Laboratories has built one of the most comprehensive veterinary-specific catheter portfolios in the market, addressing a wide spectrum of clinical needs ranging from routine urinary care to advanced vascular access and specialty applications. Its genito-urinary product line is particularly extensive, including male dog urinary catheters in 4Fr, 6Fr, 8Fr, and 10Fr sizes, along with canine female catheters, feline urinary devices, Tomcat catheters, Foley catheters, urine collection bags, and multiple catheter adapters. This breadth allows veterinary hospitals and distributors to consolidate procurement across multiple urinary-access requirements, improving inventory management, reducing supplier fragmentation, and supporting standardized clinical workflows.

In addition to urinary solutions, Jorgensen Laboratories has expanded into higher-acuity vascular access products, including extended-use polyurethane catheters and central venous catheter kits designed for intensive care and long-duration treatment scenarios. Its KatKath Tomcat catheter is engineered with a focus on clinical performance, featuring flexibility, kink resistance, an atraumatic open tip, and a rotating suture collar that enhances placement stability and reduces patient discomfort during use. The Tiny Foley catheter range, which includes 3.5Fr and 4.5Fr silicone catheters, is specifically designed for very small veterinary patients, where precision placement and minimal tissue trauma are critical to successful outcomes.

Beyond conventional catheter applications, JorVet is also extending its engineering capabilities into non-traditional clinical use cases. Its 2025 Diarrhea Collection Kit integrates a soft silicone balloon catheter with a 2,000 mL closed collection bag, available in 22Fr and 33Fr configurations. This product reflects a strategic shift toward broader fluid management and containment solutions, leveraging catheter technology to improve infection control, reduce contamination risk, and enhance nursing efficiency in hospitalized animals. By expanding catheter-based design into waste collection and fluid handling systems, Jorgensen Laboratories is positioning itself as a diversified provider of veterinary procedural solutions rather than a single-category catheter supplier.

 

B. Braun Vet Care: Integrated Infusion Ecosystem Centered on Catheter-Based Therapy

B. Braun Vet Care differentiates itself through a fully integrated infusion-therapy ecosystem, positioning catheters as one component within a broader, system-level approach to veterinary patient care. Rather than treating catheters as standalone consumables, the company combines IV catheters with infusion pumps, fluid therapy solutions, extension sets, and administration accessories. This integrated model allows B. Braun to participate across the entire fluid and drug delivery workflow in veterinary hospitals, capturing value not only from catheter sales but also from the supporting infrastructure required for infusion therapy.

A core product in its portfolio is the VasoVet catheter, manufactured from polyurethane and designed for peripheral venipuncture in both small and large animals. It incorporates an injection port, a needle-free valve, and secure fixation features that enhance safety, reduce contamination risk, and improve ease of use during vascular access procedures. For large-animal applications, the Braunüle Vet High Flow catheter is specifically engineered for horses and cattle, where high-volume fluid administration, strong fixation stability, and reliable flow performance are essential due to the physiological demands and handling challenges associated with these species.

B. Braun further strengthens its market position through a comprehensive ecosystem of supporting products that extend beyond the catheter itself. This includes IntroVet catheters, extension lines, stopcocks, skin-disinfection solutions, and central venous access systems. By integrating infection-control products and fluid administration components with its catheter offerings, the company enables veterinary hospitals to adopt standardized infusion protocols across clinical settings. This systems-based approach reduces procedural variability, enhances patient safety, and improves workflow efficiency, positioning B. Braun Vet Care as a provider of complete infusion therapy solutions rather than a supplier of individual disposable catheter products.

 

Which Regions Are Driving the Growth of the Veterinary Catheters Market?

North America Represents a Major Veterinary Catheter Market

North America holds a 39.0% share of the veterinary catheters market, with an estimated revenue of USD 323.7 million in 2025 and is projected to grow at a CAGR of 5.7%. The region combines a large companion-animal population, a mature veterinary hospital network, advanced emergency and specialty medicine, growing insurance coverage, and a strong supplier presence. The U.S. alone had approximately 163.6 million owned dogs and cats in 2025, while BLS counted 86,400 veterinarian jobs in 2024. These factors create a large recurring base of procedures involving anesthesia, surgery, IV therapy, and emergency hospitalization.

Insurance is another regional advantage. North America reached 7.6 million insured pets at year-end 2025, although this remains small compared with the total addressable animal population. Greater insurance participation can increase access to referral and emergency treatment where premium and multiple-catheter use is most likely.

North America is also commercially important because specialist suppliers such as Jorgensen Laboratories and MILA are headquartered in the U.S., while multinational companies such as B. Braun maintain strong veterinary offerings. Competition therefore extends from basic disposable catheter pricing to critical-care access, closed drainage and extended-dwell systems.

 

Key Drivers Supporting Veterinary Catheter Demand Across Europe

Europe holds a 28.0% market share in the veterinary catheters market, with an estimated 2025 revenue of USD 232.4 million, and is projected to grow at a CAGR of 6.0%. The region benefits from one of the world's largest documented companion-animal populations. FEDIAF's data published in June 2026 indicate that approximately 140 million European households, or 49%, own one or more of about 306 million pets. The scale of this animal population supports a large underlying base for surgery, anesthesia, emergency treatment and chronic veterinary care.

The UK provides a particularly useful country benchmark. UK Pet Food estimated 36.5 million pets in 2026, owned by 62% of households. This included approximately 15.5 million dogs and 13 million cats. The sizable cat population is especially relevant to urinary-catheter demand because male-cat urethral obstruction remains a routinely catheterized emergency.

European suppliers also have established capabilities in infusion and vascular-access technology. B. Braun's veterinary product portfolio spans small- and large-animal IV access, supporting competition on material quality, high-flow performance and integrated infusion systems rather than disposable price alone.

 

The growing strategic importance of Asia-Pacific for veterinary catheter suppliers

Asia-Pacific combines mature veterinary markets such as Australia with rapidly expanding urban companion-animal populations in several Asian economies, accounting for a 23.0% market share in 2025 with an estimated revenue of USD 190.9 million and a CAGR of 7.8%. Animal Medicines Australia's Pets in Australia 2025 survey estimated 31.6 million pets in 7.7 million households, with pets present in 73% of households. The population included approximately 7.3 million dogs and 5.8 million cats. Australians were estimated to spend A$21.3 billion annually on their pets, demonstrating the level of consumer expenditure available to support veterinary services and advanced treatment.

Australia is particularly relevant to urinary-catheter demand because the 2026 multicentre study of 601 catheterized male cats was conducted across five referral hospitals in Sydney, providing current evidence that sophisticated catheter-dependent emergency care is already well established in the region.

China adds a much larger emerging companion-animal base. China's 2026 pet-industry reporting estimated approximately 126 million urban dogs and cats in 2025, including 53.43 million dogs and 72.89 million cats. Increasing scale in urban companion-animal care expands the potential customer base for IV, urinary and specialty catheter suppliers, particularly as hospital capabilities become more sophisticated.

 

Latin America Opportunity for Veterinary Catheter Manufacturers

Latin America accounts for a 6.0% share of the veterinary catheters market, representing an estimated USD 49.8 million in revenue in 2025, and is projected to grow at a 6.5% CAGR, with demand led by large companion-animal markets such as Brazil, where industry data reported by Petfood Industry, citing the Brazilian Association of Pet Product Industries and Instituto Pet Brasil, indicate a pet population of more than 160 million animals, supporting steady demand for routine surgical and emergency veterinary consumables despite variability in treatment access and spending across households and regions.

 

Differences Between the Middle East and Africa and More Mature Veterinary Catheter Markets

The Middle East and Africa represent a more heterogeneous opportunity, accounting for a 4.0% market share in 2025 with an estimated revenue of USD 33.2 million and projected to grow at a CAGR of 6.3%. Companion-animal hospitals in major urban centers require the same IV and urinary access products used in established markets, but livestock, equine and working-animal care can give large-animal catheter products greater relative importance in parts of the region.

 

What Could Limit Veterinary Catheters Market Expansion?

Veterinary-care affordability is the most important commercial restraint. Catheters are individually inexpensive compared with surgery or hospitalization, but their use depends on owners authorizing the underlying treatment. Declining U.S. veterinary visit volumes despite higher practice revenue indicate that rising treatment costs can reduce utilization even in a mature market.

Catheter-related complications remain another constraint. Complication rates approaching 20% in hospitalized dogs in one prospective study show that placement alone does not guarantee durable vascular access. Poor securement, inappropriate gauge selection, phlebitis, extravasation, dislodgement and line breakage can increase replacement demand but also create pressure on hospitals to reduce catheter-associated problems.

Infection control affects urinary catheter use. The 2025 iCatCare guidelines note that catheterization increases urinary infection risk and specifically discourage open drainage. Suppliers therefore need to compete on systems that enable aseptic placement, secure connection and closed collection rather than assuming that a basic catheter alone meets current hospital requirements.

Veterinary staffing can also restrict procedure growth. Although the U.S. veterinary workforce is projected to expand, practices still depend on sufficient veterinarians and technicians to perform and monitor catheter-intensive care. Products that simplify placement, reduce repeated access attempts or require less maintenance can therefore create value through workflow efficiency as well as clinical performance.

 

Analyst Perspective: What Will Define Competition in the Veterinary Catheters Market?

Competition in the veterinary catheters market is shifting away from price alone. While basic IV and urinary catheters remain cost-sensitive, clinics now prioritize performance factors such as durability, flow rate, ease of placement, and compatibility with closed systems, especially in critical care cases.

Key players are differentiating through specialization. Jorgensen/JorVet offers a wide range covering routine, feline, large-animal, and extended-use catheters. B. Braun Vet Care integrates catheters into broader infusion and infection-control systems, while MILA focuses on specialty and critical-care catheter solutions.

Demand is strongest in high-intensity treatments like anesthesia, emergency care, long hospital stays, and feline urinary obstruction cases, where AAHA guidelines require IV access during anesthesia and closed urinary systems are recommended to reduce infection risk. These clinical needs are driving adoption of more reliable, procedure-specific catheter systems over basic disposable tubing.

 

Veterinary Catheters Market Report Coverage Table

Report Attribute	Details
Forecast Period	2026 – 2032
Market Size Value in 2025	USD 0.83 Billion
Revenue Forecast in 2032	USD 1.28 Billion
Overall Growth Rate	CAGR of 6.4% (2026 – 2032)
Base Year for Estimation	2025
Historical Data	2019 – 2024
Unit	USD Million, CAGR (2026 – 2032)
Segmentation	By Product Type, By Animal Type, By Application, By End User, By Geography
By Product Type	Peripheral Intravenous Catheters, Central Venous Catheters, Urinary Catheters, Specialty Catheters
By Animal Type	Companion Animals, Livestock Animals, Equine
By Application	Fluid Therapy and Drug Administration, Urinary Drainage and Management, Blood Collection and Transfusion, Surgery and Critical Care
By End User	Veterinary Hospitals and Clinics, Veterinary Diagnostic and Research Laboratories, Academic and Research Institutes
By Region	North America, Europe, Asia-Pacific, Latin America, Middle East and Africa
Country Scope	U.S., Canada, UK, Germany, France, Italy, China, Japan, South Korea, India, Australia, Brazil, Mexico, Saudi Arabia, UAE, South Africa
Market Drivers	Rising veterinary surgical and emergency procedures, increasing companion animal healthcare spending, growing adoption of advanced veterinary hospitals, higher demand for IV access and fluid therapy, increasing use of specialty catheter systems in critical care
Customization Option	Available upon request